Corticosteroid prophylaxis for patients receiving intravascular contrast agents: A survey of current practice in Australia and New Zealand

A survey was made of the use of corticosteroid prophylaxis in patients receiving intravascular contrast media. The replies of 807 respondents were available for analysis and they indicate that such a strategy is common for‘high-risk’patients (62.4%), but very few respondents use corticosteroid prophylaxis for all patients (0.74%).